Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation

被引:0
|
作者
M. Alt
R. Renz
P. H. Hofschneider
W. H. Caselmann
机构
[1] Department of Virus Research,
[2] Max-Planck-Institut für Biochemie,undefined
[3] Martinsried,undefined
[4] Federal Republic of Germany,undefined
来源
Archives of Virology | 1997年 / 142卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Antisense phosphorothioate oligodeoxynucleotides (S-ODN) complementary to sequence stretches in the 5′ non coding region (NCR) of the hepatitis C virus (HCV) have recently been shown to effectively inhibit viral gene expression. In order to further delineate the optimum target region in the highly conserved 5′ end of the viral RNA, S-ODN complementary to HCV core coding sequences were analysed in the present study. In a rabbit reticulocyte lysate (RRL) in vitro translation assay S-ODN 5, complementary to the HCV-RNA nucleotides 340–353, and S-ODN-6, complementary to nucleotides 348–365, resulted in an inhibition of viral translation of 90.4± 1.3% and 93.7± 5.1%, respectively at a concentration of 4.14 µM. S-ODN 7, complementary to nucleotides 371–388, was relatively inefficient and showed a maximal inhibition of 42.4± 12.2% It has been suggested that in living cells an inhibition by S-ODN is mainly mediated by the action of RNAse H. In RRL the RNAseH content is very low; therefore, to simulate the situation in living cells inhibition experiments in RRL enriched with RNAse H were performed. Under these conditions S-ODN 5, 6 and 7 inhibited viral translation by 45.6± 6.3%, 80.3± 2.8% and 70.9± 5.7% at concentrations as low as 0.2 µM. At this concentration no inhibition was observed in the standard RRL assay. In cell culture S-ODN 7 was by far the most efficient inhibitor of viral translation, resulting in a specific inhibition of 89.4± 3.6% at a concentration of 0.3 µM. Taken together with the results of our previous study, nucleotides 326–348 comprising the 3′ end of the NCR and nucleotides 371–388, located entirely in the core coding region of the HCV RNA, are effective targets for S-ODN mediated inhibition of viral translation.
引用
收藏
页码:589 / 599
页数:10
相关论文
共 50 条
  • [41] Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and in mice
    Leonetti, C
    DAgnano, I
    Lozupone, F
    Valentini, A
    Geiser, T
    Zon, G
    Calabretta, B
    Citro, G
    Zupi, G
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (07): : 419 - 429
  • [42] Cell-specific optimization of phosphorothioate antisense oligodeoxynucleotide delivery by cationic lipids
    Williams, SA
    Buzby, JS
    ANTISENSE TECHNOLOGY, PT A: GENERAL METHODS, METHODS OF DELIVERY, AND RNA STUDIES, 2000, 313 : 388 - 397
  • [43] Characterization of antisense oligodeoxynucleotides (ODN) and proteinase inhibitors that inhibit hepatitis C virus NS3 function.
    Encke, HT
    Zu, J
    Wands, PJ
    HEPATOLOGY, 1998, 28 (04) : 286A - 286A
  • [44] POTENT AND SPECIFIC INHIBITORS OF PROTEIN KINASE-C OF MICROBIAL ORIGIN
    TAMAOKI, T
    NAKANO, H
    BIO-TECHNOLOGY, 1990, 8 (08): : 732 - 735
  • [45] Substituted imidazopyridines as potent inhibitors of hepatitis C virus replication that target the viral polymerase
    Vliegen, Inge
    Paeshuyse, Jan
    Lehman, Laura S.
    Zhong, Wei-dong
    Roofthooft, Sofie
    Dutartre, Helene
    Selisko, Barbara
    Canard, Bruno
    Boddeker, Nina
    Bondy, Steven
    Oare, David
    De Clercq, Erik
    Lee, William A.
    Purstinger, Gerhard
    Neyts, Johan
    ANTIVIRAL RESEARCH, 2007, 74 (03) : A37 - A37
  • [46] SPECIFIC SUPPRESSION OF T-CELL SURFACE-ANTIGENS WITH ANTISENSE OLIGODEOXYNUCLEOTIDES
    HEALD, P
    LATKOWSKI, J
    GASPARRO, F
    YAN, SL
    EDELSON, R
    CLINICAL RESEARCH, 1990, 38 (02): : A618 - A618
  • [47] SPECIFIC-INHIBITION OF NA-CA EXCHANGE FUNCTION BY ANTISENSE OLIGODEOXYNUCLEOTIDES
    LIPP, P
    SCHWALLER, B
    NIGGLI, E
    FEBS LETTERS, 1995, 364 (02) : 198 - 202
  • [48] SPECIFIC SUPPRESSION OF T-CELL SURFACE-ANTIGENS WITH ANTISENSE OLIGODEOXYNUCLEOTIDES
    HEALD, P
    LATKOWSKI, J
    GASPARRO, F
    YAN, SL
    EDELSON, R
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (04) : 533 - 533
  • [49] Activation of hepatitis C virus translation by a liver-specific microRNA
    Niepmann, Michael
    CELL CYCLE, 2009, 8 (10) : 1473 - 1477
  • [50] Alternate translation occurs within the core coding region of the hepatitis C viral genome
    Varaklioti, A
    Vassilaki, N
    Georgopoulou, U
    Mavromara, P
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) : 17713 - 17721